Pluto Immunotherapeutics, Inc.

Biotechnology company · Los Angeles, California, United States

Pluto Immunotherapeutics, Inc. is a biotechnology company headquartered in Los Angeles, California, United States. Its earliest recorded incorporation is in 2020. It has reported private securities offerings to the US SEC, most recently $2.8 million sold in a notice filed in 2022.

Profile compiled from public records. Is this your company? Request a correction or update

Pluto Immunotherapeutics at a glance

Typebiotechnology company
HeadquartersLos Angeles, California, United States
Earliest incorporation on record2020
SEC CIK1831908

What does Pluto Immunotherapeutics do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $2.8 million sold (2022).

Frequently asked questions about Pluto Immunotherapeutics

Where is Pluto Immunotherapeutics headquartered?

Pluto Immunotherapeutics, Inc. is headquartered in Los Angeles, California, United States.

What does Pluto Immunotherapeutics do?

Pluto Immunotherapeutics, Inc. is a biotechnology company.

When was Pluto Immunotherapeutics founded?

The earliest incorporation on record for Pluto Immunotherapeutics, Inc. is in 2020, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences